Glutamine and Whey Protein Improve Intestinal Permeability and Morphology in Patients with Crohn’s Disease: A Randomized Controlled Trial
- 1.2k Downloads
Increased intestinal permeability (IP) has been implicated in the etiopathogenesis, disease activity and relapse of Crohn’s disease (CD). Glutamine, the major fuel for the enterocytes, may improve IP.
We evaluated the effect of oral glutamine on IP and intestinal morphology in patients with CD.
In a randomized controlled trial, consecutive patients with CD in remission phase with an abnormal IP were randomized to a glutamine group (GG) or active control group (ACG) and were given oral glutamine or whey protein, respectively, as 0.5 g/kg ideal body weight/day for 2 months. IP was assessed by the lactulose mannitol excretion ratio (LMR) in urine, and morphometry was performed by computerized image analysis system.
Patients (age 34.5 ± 10.5 years; 20 males) were assigned to the GG (n = 15) or ACG (n = 15). Fourteen patients in each group completed the trial. The LMR [median (range)] in GG and ACG at 2 months was 0.029 (0.006–0.090) and 0.033 (0.009–0.077), respectively, with P = 0.6133. IP normalized in 8 (57.1%) patients in each group (P = 1.000). The villous crypt ratio (VCR) [mean (SD)] in GG and ACG at 2 months was 2.68 (1.02) and 2.49 (0.67), respectively, (P = 0.347). At the end of 2 months LMR improved significantly in GG from 0.071 (0.041–0.254) to 0.029 (0.006–0.090) (P = 0.0012) and in ACG from 0.067 (0.040–0.136) to 0.033 (0.009–0.077) (P = 0.0063). VCR improved in the GG from 2.33 (0.77) to 2.68 (1.02) (P = 0.001), and in ACG from 2.26 (0.57) to 2.49 (0.67) (P = 0.009).
Intestinal permeability and morphology improved significantly in both glutamine and ACG.
KeywordsCrohn’s disease Glutamine Intestinal morphology Intestinal permeability Lactulose mannitol ratio Villous crypt ratio
We acknowledge the Indian Council of Medical Research (ICMR) for providing a research grant to carry out this work, Claris lifesciences Ltd. India, for providing glutamine for 15 patients for 2 months and Mahaan Proteins Ltd, India, for providing whey protein for 15 patients for 2 months.
Conflict of interest
There is no conflict of interest in this work.
- 8.Hollander D. Intestinal permeability in health and disease. In: Kirsner JB, ed. Inflammatory bowel disease. Philadelphia: Saunders; 2000:45–54.Google Scholar
- 27.Zoli G, Care M, Falco F, Spano C, Bernardi R, Gasbamini G. Effect of oral glutamine on intestinal permeability and nutritional status in Crohn’s disease. Gastroenterology. 1995;108:A766.Google Scholar
- 30.Gopalan C, Rama Sastri BV, Balasubramanian SC. Nutritive Value of Indian Foods. National Institute of Nutrition, Indian Council of Medical Research, Hyderabad; 1989.Google Scholar
- 31.Corcoran A, Page J. A method for determination of mannitol in plasma and urine. J Biol Chem. 1947;170:165–171.Google Scholar
- 33.Teerlink T, van Leeuwen PAM, Houdijk A. Plasma amino acids determined by liquid chromatography within 17 min. Clin Chem. 1994;40:245–249.Google Scholar
- 46.De Marco VG, Li N, Thomas J, West CM, Neu J. Glutamine and barrier function in cultured Caco-2 epithelial cell monolayer. J Nutr. 2003;133:2176–2179.Google Scholar
- 57.Windemueller HG, Spaeth AE. Identification of ketone bodies and glutamine as the major respiratory fuels in vivo for postabsorptive rat small intestine. J Biol Chem. 1978;253:69–76.Google Scholar